Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.

Abstract

Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

6 Figures and Tables

05001000'04'06'08'10'12'14'16
Citations per Year

7,933 Citations

Semantic Scholar estimates that this publication has 7,933 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Racusen2003AntibodymediatedRC, title={Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection.}, author={Lorraine C. Racusen and Robert B. Colvin and Kim Solez and Michael J{\"{o}rg Mihatsch and Philip Halloran and Patricia M. Campbell and Michael J Cecka and Jean-Pierre Cosyns and Anthony Jake Demetris and Michael C. Fishbein and Agnes B . Fogo and Peter N. Furness and Ian W. Gibson and Denis Glotz and Pekka J. Hayry and Lawrence Hunsickern and Michael Kashgarian and Ronald H . Kerman and Alex J Magil and Robert A Montgomery and Kunio Morozumi and Volker Nickeleit and Parmjeet Singh Randhawa and Heinz M Regele and Daniel Ser{\'o}n and Surya V. Seshan and St{\aa}le Sund and Kiril Trpkov}, journal={American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons}, year={2003}, volume={3 6}, pages={708-14} }